Merck & Co., Inc. Share Price

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse 01:30:02 01/06/2024 am IST 5-day change 1st Jan Change
125.5 USD +0.81% Intraday chart for Merck & Co., Inc. -3.05% +15.15%
Sales 2024 * 64.12B 5,348B Sales 2025 * 68.54B 5,717B Capitalization 318B 26,522B
Net income 2024 * 19.51B 1,627B Net income 2025 * 22.25B 1,856B EV / Sales 2024 * 5.25 x
Net Debt 2024 * 18.6B 1,551B Net Debt 2025 * 7.29B 608B EV / Sales 2025 * 4.75 x
P/E ratio 2024 *
16.2 x
P/E ratio 2025 *
14.1 x
Employees 71,000
Yield 2024 *
2.46%
Yield 2025 *
2.61%
Free-Float 70.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.81%
1 week-3.05%
1 month-2.85%
3 months-1.27%
6 months+22.50%
Current year+15.15%
More quotes
1 week
122.70
Extreme 122.7
129.08
1 month
122.70
Extreme 122.7
132.79
Current year
109.16
Extreme 109.16
133.10
1 year
99.14
Extreme 99.14
133.10
3 years
70.89
Extreme 70.89
133.10
5 years
65.25
Extreme 65.25
133.10
10 years
45.69
Extreme 45.69
133.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 01/14/01
Director of Finance/CFO 55 01/90/01
Chief Tech/Sci/R&D Officer 55 01/20/01
Members of the board TitleAgeSince
Director/Board Member 63 27/07/27
Director/Board Member 67 01/15/01
Director/Board Member 69 01/18/01
More insiders
Date Price Change Volume
31/24/31 125.5 +0.81% 18,150,452
30/24/30 124.5 -1.09% 13,003,476
29/24/29 125.9 -0.15% 8,527,837
28/24/28 126.1 -2.63% 10,263,383
24/24/24 129.5 -1.22% 5,983,846

Delayed Quote Nyse, May 01, 2024 at 01:30 am IST

More quotes
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus